Nathan Fielder and Lance Oppenheim have returned with a new cinematic project that is rapidly taking over social media and early box office discussions. Released in theaters on a Thursday night, the film centers largely on Theranos fraudster Elizabeth Holmes while weaving a complex narrative web that has left initial audiences astounded. Early metrics show a rare 100 percent score on Rotten Tomatoes, alongside a 99 percent rating on Fandango and an initial 9.3 on IMDb. That early score places it neck-and-neck with perennial favorites like The Shawshank Redemption, though the platform's standard Top 250 list traditionally excludes documentaries and short films.
While enthusiastic theatergoers are hailing the feature as an artistic triumph, questions linger regarding its official genre classification. Fielder has a well-documented history of dismantling the boundaries between scripted fiction and unscripted reality in his previous work. This latest project continues that trend, challenging viewers to decide exactly what constitutes a documentary. Featuring unexpected turns, an appearance by an A-list celebrity, and a content warning for full-frontal nudity, the project defies easy categorization and refuses to play by conventional rules.
Achieving a lasting spot among the highest-rated titles on aggregator sites requires passing strict community thresholds. The film currently sits at roughly 1,000 user ratings on IMDb, well short of the 25,000-user minimum required for the top-rated feature film index. Even so, comparisons to widely discussed releases indicate that crossing that volume threshold is likely just a matter of time. As broader audiences experience the three-hour runtime and encounter its narrative twists, industry watchers will be monitoring how the critical consensus stabilizes in the coming weeks.
Comments